Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The price of Phathom Pharmaceuticals Inc (NASDAQ: PHAT) closed at $5.41 in the last session, down -5.25% from day before closing price of $5.71. In other words, the price has decreased by -$5.25 from its previous closing price. On the day, 1.04 million shares were traded.
Ratios:
We take a closer look at PHAT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.68 and its Current Ratio is at 5.73.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on May 03, 2024, initiated with a Buy rating and assigned the stock a target price of $24.
On January 05, 2024, Needham reiterated its Buy rating and also lowered its target price recommendation from $23 to $26.
On August 09, 2023, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $28.H.C. Wainwright initiated its Buy rating on August 09, 2023, with a $28 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 21 ’25 when Henderson Molly sold 6,583 shares for $6.59 per share. The transaction valued at 43,371 led to the insider holds 93,546 shares of the business.
Nabulsi Azmi sold 7,886 shares of PHAT for $51,957 on Jan 21 ’25. The Chief Operating Officer now owns 233,390 shares after completing the transaction at $6.59 per share. On Jan 21 ’25, another insider, Curran Terrie, who serves as the President and Chief Executive of the company, sold 19,109 shares for $6.59 each. As a result, the insider received 125,884 and left with 360,465 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 14.08.
Stock Price History:
Over the past 52 weeks, PHAT has reached a high of $19.71, while it has fallen to a 52-week low of $5.42. The 50-Day Moving Average of the stock is -27.56%, while the 200-Day Moving Average is calculated to be -53.66%.
Shares Statistics:
A total of 68.32M shares are outstanding, with a floating share count of 34.44M. Insiders hold about 49.63% of the company’s shares, while institutions hold 69.51% stake in the company.
